Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Archivo Médico de Camagüey
versión On-line ISSN 1025-0255
Resumen
PEREZ-OJEDA, Yoan et al. Epidemiological, clinical and laboratory characterization in persistent positive COVID-19 patients. Arch méd Camagüey [online]. 2023, vol.27 Epub 08-Jul-2023. ISSN 1025-0255.
Introduction:
COVID-19 is a global concern, it requires a comprehensive approach to reduce transmission, starting with case detection, hospital care and subsequent follow-up.
Objective:
To characterize persistent COVID-19 positive patients in terms of epidemiology, clinical and laboratory data.
Methods:
A cross-sectional descriptive study was carried out in 16 persistent SARS-CoV-2 positive patients diagnosed by RT-CPR in nasopharyngeal swab, at Comandante Manuel Fajardo Rivero Hospital of Santa Clara in the period from September 2020 to November 2020.
Results:
The female sex predominated in 75%, the most representative age group was 40-59 years of age (68.75%), 37.50% of the cases were asymptomatic and the most frequent symptom was fever less than seven days 31.25%. There was lymphopenia in the initial hemogram with an average of 27.49, and a leukocyte neutrophil index above three in 4 patients with an initial average of 3.42. Hospital stay of 20.75 days on average. Half had no history of known disease, the most frequent comorbidity was arterial hypertension 43.75 %. The neutrophil leukocyte index above 3 in patients with comorbidities, evolutionary for all pariente was less than 3.
Conclusions:
The female sex predominates, the most representative age group is 40-59 years, it is frequent that they present asymptomatic and fever is the most usual symptom. There is lymphopenia on the initial blood count. Half of those infected without comorbidities. The evolutionary leukocyte neutrophil index was less than 3 for all patients.
Palabras clave : COVID-19/epidemiology; SARS-CoV-2; COMORBIDITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SECONDARY CARE.